Market Insights Health Pharmacies OTC Products

Sleep Aids (Pharmacies) - Netherlands

Netherlands

Revenue in the Sleep Aids market is projected to reach €33.17m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.99%, resulting in a market volume of €36.61m by 2029.
In global comparison, most revenue will be generated in the United States (€1,366.00m in 2024).
In relation to total population figures, per person revenues of €1.88 are generated in 2024.

Key regions: United States, Germany, Australia, India, United Kingdom

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Sleep Aids (Pharmacies) market in Netherlands has witnessed significant growth in recent years. Customer preferences have shifted towards natural and non-habit forming sleep aids, driving the demand for such products in the market. Additionally, the rising prevalence of sleep disorders and increasing awareness about the importance of good sleep hygiene have also contributed to the growth of the market.

Customer preferences: In recent years, there has been a growing preference among customers in Netherlands for natural sleep aids. Customers are increasingly seeking products that are derived from natural ingredients and have minimal side effects. This shift in preference can be attributed to the rising awareness about the potential risks and dependency associated with traditional sleep aids. As a result, there has been a surge in the demand for herbal and homeopathic sleep aids in the market.

Trends in the market: One of the key trends in the Sleep Aids (Pharmacies) market in Netherlands is the increasing availability of over-the-counter (OTC) sleep aids. OTC sleep aids are easily accessible to customers without the need for a prescription, making them a convenient option for those seeking immediate relief from sleep problems. This trend has contributed to the overall growth of the market, as it has expanded the customer base for sleep aids. Another trend in the market is the growing popularity of sleep aids that promote relaxation and stress reduction. With the fast-paced and stressful lifestyle of many individuals in Netherlands, there is a high demand for sleep aids that not only help in inducing sleep but also aid in relaxation. Sleep aids that contain ingredients such as chamomile, lavender, and melatonin are increasingly preferred by customers who are looking for a holistic approach to sleep improvement.

Local special circumstances: Netherlands has a well-developed healthcare system and a high level of healthcare awareness among its population. This has led to an increased focus on sleep disorders and the availability of sleep aids in the market. The presence of a large number of pharmacies across the country ensures easy access to sleep aids for customers. Furthermore, the government has implemented regulations to ensure the safety and efficacy of sleep aids sold in the market, which has further boosted customer confidence in these products.

Underlying macroeconomic factors: The Sleep Aids (Pharmacies) market in Netherlands is influenced by several macroeconomic factors. The growing aging population in the country has contributed to the increasing prevalence of sleep disorders, driving the demand for sleep aids. Additionally, the rising disposable income levels and improving standard of living have made sleep aids more affordable and accessible to a larger segment of the population. Furthermore, the increasing awareness about the importance of good sleep hygiene and the negative impacts of sleep disorders on overall health have also played a role in the growth of the market. In conclusion, the Sleep Aids (Pharmacies) market in Netherlands has experienced significant growth due to customer preferences for natural sleep aids, the availability of OTC sleep aids, and the growing awareness about sleep disorders. The local special circumstances, such as a well-developed healthcare system and government regulations, have further supported the growth of the market. The underlying macroeconomic factors, including the aging population and rising disposable income levels, have also contributed to the development of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.